- Needham cut Medtronic plc MDT price target from $131 to $128. Medtronic shares fell 0.7% to $103.44 in pre-market trading.
- Deutsche Bank cut Bill.com Holdings, Inc. BILL price target from $360 to $265. Bill.com shares fell 4.2% to $159.80 in pre-market trading.
- Stifel lowered Blueprint Medicines Corporation BPMC price target from $120 to $95. Blueprint Medicines shares rose 1.8% to $73.59 in pre-market trading.
- Berenberg raised the price target for Delta Air Lines, Inc. DAL from $48 to $50. Delta Air shares fell 0.4% to $37.76 in pre-market trading.
- Keybanc reduced the price target on Intuit Inc. INTU from $750 to $700. Intuit shares fell 0.3% to $532.99 in pre-market trading.
Also check out these big insider trades here
- SVB Leerink boosted Allscripts Healthcare Solutions, Inc. MDRX price target from $19 to $22. Allscripts Healthcare shares rose 4% to $18.18 in pre-market trading.
- JMP Securities cut the price target on eFFECTOR Therapeutics, Inc. EFTR from $33 to $8. eFFECTOR Therapeutics shares fell 6.1% to close at $6.03 on Monday.
- Keybanc lowered the price target for Shopify Inc. SHOP from $1,750 to $1,250. Shopify shares fell 2.2% to $918.00 in pre-market trading.
- Mizuho cut Fidelity National Information Services, Inc. FIS price target from $160 to $150. Fidelity National Information shares fell 0.1% to $111.74 in pre-market trading.
- Needham lowered the price target on Wayfair Inc. W from $280 to $225. Wayfair shares fell 3.1% to $148.00 in pre-market trading.
Check out other big price target changes here
Loading...
Loading...
BILLBILL Holdings Inc
$45.38-4.61%
Edge Rankings
Momentum
23.74
Growth
83.81
Quality
-
Value
0.51
Price Trend
Short
Medium
Long
BPMCBlueprint Medicines Corp
$97.17-1.61%
DALDelta Air Lines Inc
$48.20-0.70%
EFTReFFECTOR Therapeutics Inc
$0.078339050.0%
FISFidelity National Information Services Inc
$78.340.54%
INTUIntuit Inc
$653.88-0.34%
MDRXVeradigm Inc
$4.30-4.23%
MDTMedtronic PLC
$84.000.45%
SHOPShopify Inc
$91.50-2.66%
WWayfair Inc
$32.90-2.17%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in